N/A Completed N=29 Diagnostic

3D MR Versus 3D CT for Glenohumeral Arthritis

Arthritis · Glenohumeral Osteoarthritis

Source: ClinicalTrials.gov NCT03379545 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Apr 2020

Primary outcomePrimary: Glenoid Version — 12.1; 11.4 degrees

Summary

This study aims to assess the efficacy of three-dimensional magnetic resonance (MR) compared to three-dimensional computed tomography (CT) imaging. This proposed study is a prospective, unrandomized, single-blinded, self-controlled, and single-armed diagnostic radiological evaluation study.

Outcome Measures

Outcome	Result	p-value
PRIMARY Glenoid Version	12.1; 11.4	—
PRIMARY Glenoid Inclination	89.2; 91	—

Eligibility Criteria

Inclusion Criteria

Patients suffering from glenohumeral OA;
Radiographic evidence of severe glenoid erosion;
Indication for TSA based on clinical exam;
Patient is willing to participate by complying with pre-operative visit requirements;
Patient is willing and able to review and sign a study informed consent form.

Exclusion Criteria

Prior arthroplasty at the affected shoulder;
Patients with inflammatory arthritis;
Patients with post-capsulorrhaphy arthritis;
Patients with post-traumatic arthritis;
Patients with rotator cuff tear arthropathy;
Patients exhibiting a lack of physical or mental ability to perform or comply with the study procedures;
Patients who are pregnant;
Patients with implanted medical devices that are contraindicated to exposure up to a 3.0-tesla magnetic field.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03379545). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.